Urgent info for people taking a GLP-1 analogue for Type 2 Diabetes
GLP-1 analogues for Type 2 Diabetes
There is a worldwide shortage of injectable and oral GLP-1 analogue receptor agonist (GLP-1s) medicines for type 2 diabetes. These include Dulaglutide (Trulicity®), Exenatide (Byetta® or Bydureon®), Semaglutide (Ozempic® or Rybelsus®), Liraglutide (Victoza®) and Lixisenatide (Lyxumia®).
Due to increased global use, manufacturers are currently unable to produce enough of these diabetic injectable medicines to meet demand. Supply is not expected to return to normal until at least the middle of 2024.
All patients using GLP-1 analogues will be contacted over the coming weeks to arrange a medication review and a blood test. It is important to attend the practice or hospital when you receive this request.
Please remember that GLP-1 RAs should only be obtained on prescription from registered pharmacies. It is illegal to obtain GLP-1 RA without a prescription and there is a risk that the medicine may not be genuine.
If you feel unwell with symptoms of high blood glucose, please seek medical help as normal. For general queries about how long the shortage will last, please remember this is beyond our control and we are dealing with a high volume of calls.
Urgent information for people taking a GLP v2 (1)
Coffee Morning
The Little Orange Book
Click here to open "The Little Orange Book"
Northern Gambling Service
#DOYOURBIT
A Healthy Start
PAINKILLERS DON'T EXIST
Age UK
Local Support
Financial Support
Support for Mental Wellbeing
Suffering with Hay Fever?
If you are suffering with hay fever this summer and need advice, please download the latest hay fever information leaflet agreed by the CCG.
Hay Fever Leaflet